Fervida

Fervida Therapeutics is a pre-clinical stage biotechnology company focused on developing novel small molecule therapeutics for oncology. The company leverages expertise in chemical biology and covalent chemistry to target proteins previously considered undruggable. Founded by leading scientists in the field of kinase inhibition and chemical genetics, Fervida aims to create high-affinity degraders and inhibitors to address unmet needs in solid tumors. The company's approach combines proprietary screening technologies with advanced medicinal chemistry to expand the reach of targeted protein degradation. Fervida is currently building a robust pipeline of candidates aimed at providing transformative outcomes for cancer patients.